FMR LLC - VAXCYTE INC ownership

VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 200 filers reported holding VAXCYTE INC in Q2 2023. The put-call ratio across all filers is 4.14 and the average weighting 0.5%.

Quarter-by-quarter ownership
FMR LLC ownership history of VAXCYTE INC
ValueSharesWeighting
Q3 2023$717,647,365
+2.2%
14,077,037
+0.1%
0.06%
+5.1%
Q2 2023$701,968,411
-20.7%
14,056,236
-40.5%
0.06%
+47.5%
Q1 2023$885,170,052
+81.5%
23,617,130
+132.2%
0.04%
-16.7%
Q4 2022$487,617,048
+128.4%
10,169,282
+14.3%
0.05%
+118.2%
Q3 2022$213,533,000
+15.3%
8,897,197
+4.5%
0.02%
+22.2%
Q2 2022$185,253,000
-8.4%
8,513,406
+1.6%
0.02%
+12.5%
Q1 2022$202,304,000
+8.0%
8,376,942
+6.4%
0.02%
+14.3%
Q4 2021$187,331,000
-5.7%
7,874,350
+0.6%
0.01%
-12.5%
Q3 2021$198,605,000
+14.5%
7,828,385
+1.6%
0.02%
+14.3%
Q2 2021$173,480,000
+14.1%
7,706,809
+0.1%
0.01%
+7.7%
Q1 2021$152,059,000
-25.1%
7,699,143
+0.7%
0.01%
-27.8%
Q4 2020$203,058,000
-35.5%
7,642,405
+19.9%
0.02%
-43.8%
Q3 2020$314,836,000
+111.6%
6,375,763
+35.5%
0.03%
+100.0%
Q2 2020$148,780,0004,706,7590.02%
Other shareholders
VAXCYTE INC shareholders Q2 2023
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 1,049,893$53,523,54517.09%
Pivotal bioVenture Partners Investment Advisor LLC 793,036$40,429,12816.12%
Kynam Capital Management, LP 1,302,407$66,396,70910.86%
RA Capital Management 7,891,254$402,296,1297.92%
COMMODORE CAPITAL LP 1,100,000$56,078,0006.56%
GREAT POINT PARTNERS LLC 531,211$27,081,1374.93%
ACUTA CAPITAL PARTNERS, LLC 121,022$6,169,7024.14%
Frazier Life Sciences Management, L.P. 1,164,405$59,361,3673.94%
Novo Holdings A/S 845,000$43,078,1003.18%
BRAIDWELL LP 1,619,553$82,564,8122.61%
View complete list of VAXCYTE INC shareholders